{"id":973,"date":"2026-01-16T11:20:57","date_gmt":"2026-01-16T10:20:57","guid":{"rendered":"https:\/\/cardiateam.eu\/?p=973"},"modified":"2026-01-16T11:20:57","modified_gmt":"2026-01-16T10:20:57","slug":"bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i","status":"publish","type":"post","link":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/","title":{"rendered":"Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i"},"content":{"rendered":"<p><strong>Authors:<\/strong><\/p>\n<p>Makoto\u00a0Harada, Jonathan\u00a0Adam, Marcela\u00a0Covic, Jianhong\u00a0Ge, Stefan\u00a0Brandmaier, Caroline\u00a0Muschet, Jialing\u00a0Huang, Siyu\u00a0Han, Martina\u00a0Rommel, Markus\u00a0Rotter, Margit\u00a0Heier, Robert P.\u00a0Mohney, Jan\u00a0Krumsiek, Gabi\u00a0Kastenm\u00fcller, Wolfgang\u00a0Rathmann, Zhongmei\u00a0Zou, Sven\u00a0Zukunft, Markus F.\u00a0Scheerer, Susanne\u00a0Neschen, Jerzy\u00a0Adamski, Christian\u00a0Gieger, Annette\u00a0Peters, Donna P.\u00a0Ankerst, Thomas\u00a0Meitinger, Tanya L.\u00a0Alderete, Martin Hrabe\u00a0de\u00a0Angelis Karsten\u00a0Suhre and Rui\u00a0Wang-Sattler<\/p>\n<p>&nbsp;<\/p>\n<p>Harada et al. Cardiovascular Diabetology (2024) 23:199<\/p>\n<p>doi: https:\/\/doi.org\/10.1186\/s12933-024-02288-x<\/p>\n<p>Published: 12 June 2024<\/p>\n<p>&nbsp;<\/p>\n<p><strong>Abstract:<\/strong><\/p>\n<p class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Background<\/p>\n<p>Metformin and sodium-glucose-cotransporter-2 inhibitors (SGLT2i) are cornerstone therapies for managing hyperglycemia in diabetes. However, their detailed impacts on metabolic processes, particularly within the citric acid (TCA) cycle and its anaplerotic pathways, remain unclear. This study investigates the tissue-specific metabolic effects of metformin, both as a monotherapy and in combination with SGLT2i, on the TCA cycle and associated anaplerotic reactions in both mice and humans.<\/p>\n<p class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Methods<\/p>\n<p>Metformin-specific metabolic changes were initially identified by comparing metformin-treated diabetic mice (MET) with vehicle-treated db\/db mice (VG). These findings were then assessed in two human cohorts (KORA and QBB) and a longitudinal KORA study of metformin-na\u00efve patients with Type 2 Diabetes (T2D). We also compared MET with db\/db mice on combination therapy (SGLT2i\u2009+\u2009MET). Metabolic profiling analyzed 716 metabolites from plasma, liver, and kidney tissues post-treatment, using linear regression and Bonferroni correction for statistical analysis, complemented by pathway analyses to explore the pathophysiological implications.<\/p>\n<p class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Results<\/p>\n<p>Metformin monotherapy significantly upregulated TCA cycle intermediates such as malate, fumarate, and \u03b1-ketoglutarate (\u03b1-KG) in plasma, and anaplerotic substrates including hepatic glutamate and renal 2-hydroxyglutarate (2-HG) in diabetic mice. Downregulated hepatic taurine was also observed. The addition of SGLT2i, however, reversed these effects, such as downregulating circulating malate and \u03b1-KG, and hepatic glutamate and renal 2-HG, but upregulated hepatic taurine. In human T2D patients on metformin therapy, significant systemic alterations in metabolites were observed, including increased malate but decreased citrulline. The bidirectional modulation of TCA cycle intermediates in mice influenced key anaplerotic pathways linked to glutaminolysis, tumorigenesis, immune regulation, and antioxidative responses.<\/p>\n<p class=\"c-article__sub-heading\" data-test=\"abstract-sub-heading\">Conclusion<\/p>\n<p>This study elucidates the specific metabolic consequences of metformin and SGLT2i on the TCA cycle, reflecting potential impacts on the immune system. Metformin shows promise for its anti-inflammatory properties, while the addition of SGLT2i may provide liver protection in conditions like metabolic dysfunction-associated steatotic liver disease (MASLD). These observations underscore the importance of personalized treatment strategies.<\/p>\n<p><a href=\"https:\/\/link.springer.com\/article\/10.1186\/s12933-024-02288-x\" target=\"_blank\" rel=\"noopener\"><br \/>\nRead full publication<br \/>\n<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Authors: Makoto\u00a0Harada, Jonathan\u00a0Adam, Marcela\u00a0Covic, Jianhong\u00a0Ge, Stefan\u00a0Brandmaier, Caroline\u00a0Muschet, Jialing\u00a0Huang, Siyu\u00a0Han, Martina\u00a0Rommel, Markus\u00a0Rotter, Margit\u00a0Heier, Robert P.\u00a0Mohney, Jan\u00a0Krumsiek, Gabi\u00a0Kastenm\u00fcller, Wolfgang\u00a0Rathmann, Zhongmei\u00a0Zou, Sven\u00a0Zukunft, Markus F.\u00a0Scheerer, Susanne\u00a0Neschen, Jerzy\u00a0Adamski, Christian\u00a0Gieger, Annette\u00a0Peters, Donna P.\u00a0Ankerst, Thomas\u00a0Meitinger, Tanya L.\u00a0Alderete, Martin Hrabe\u00a0de\u00a0Angelis Karsten\u00a0Suhre and Rui\u00a0Wang-Sattler &nbsp; Harada et al. Cardiovascular Diabetology (2024) 23:199 doi: https:\/\/doi.org\/10.1186\/s12933-024-02288-x Published: 12 June 2024 &nbsp; Abstract: Background Metformin and sodium-glucose-cotransporter-2&hellip;<\/p>\n","protected":false},"author":1,"featured_media":974,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[8],"tags":[],"class_list":["post-973","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publications"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.4 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i - Cardiateam<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i - Cardiateam\" \/>\n<meta property=\"og:description\" content=\"Authors: Makoto\u00a0Harada, Jonathan\u00a0Adam, Marcela\u00a0Covic, Jianhong\u00a0Ge, Stefan\u00a0Brandmaier, Caroline\u00a0Muschet, Jialing\u00a0Huang, Siyu\u00a0Han, Martina\u00a0Rommel, Markus\u00a0Rotter, Margit\u00a0Heier, Robert P.\u00a0Mohney, Jan\u00a0Krumsiek, Gabi\u00a0Kastenm\u00fcller, Wolfgang\u00a0Rathmann, Zhongmei\u00a0Zou, Sven\u00a0Zukunft, Markus F.\u00a0Scheerer, Susanne\u00a0Neschen, Jerzy\u00a0Adamski, Christian\u00a0Gieger, Annette\u00a0Peters, Donna P.\u00a0Ankerst, Thomas\u00a0Meitinger, Tanya L.\u00a0Alderete, Martin Hrabe\u00a0de\u00a0Angelis Karsten\u00a0Suhre and Rui\u00a0Wang-Sattler &nbsp; Harada et al. Cardiovascular Diabetology (2024) 23:199 doi: https:\/\/doi.org\/10.1186\/s12933-024-02288-x Published: 12 June 2024 &nbsp; Abstract: Background Metformin and sodium-glucose-cotransporter-2&hellip;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/\" \/>\n<meta property=\"og:site_name\" content=\"Cardiateam\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-16T10:20:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/8.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"316\" \/>\n\t<meta property=\"og:image:height\" content=\"446\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"admin2269\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin2269\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/\"},\"author\":{\"name\":\"admin2269\",\"@id\":\"https:\/\/cardiateam.eu\/#\/schema\/person\/8d3259e0b35aa41c93af6f7c3d340ca4\"},\"headline\":\"Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i\",\"datePublished\":\"2026-01-16T10:20:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/\"},\"wordCount\":421,\"publisher\":{\"@id\":\"https:\/\/cardiateam.eu\/#organization\"},\"image\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/8.webp\",\"articleSection\":[\"Publications\"],\"inLanguage\":\"en-GB\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/\",\"url\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/\",\"name\":\"Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i - Cardiateam\",\"isPartOf\":{\"@id\":\"https:\/\/cardiateam.eu\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/8.webp\",\"datePublished\":\"2026-01-16T10:20:57+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#primaryimage\",\"url\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/8.webp\",\"contentUrl\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/8.webp\",\"width\":316,\"height\":446},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/cardiateam.eu\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cardiateam.eu\/#website\",\"url\":\"https:\/\/cardiateam.eu\/\",\"name\":\"Cardiateam\",\"description\":\"Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches\",\"publisher\":{\"@id\":\"https:\/\/cardiateam.eu\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cardiateam.eu\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cardiateam.eu\/#organization\",\"name\":\"Cardiateam\",\"url\":\"https:\/\/cardiateam.eu\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/cardiateam.eu\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2019\/07\/cropped-CARDIATEAM-logo-1.png\",\"contentUrl\":\"https:\/\/cardiateam.eu\/wp-content\/uploads\/2019\/07\/cropped-CARDIATEAM-logo-1.png\",\"width\":3486,\"height\":1434,\"caption\":\"Cardiateam\"},\"image\":{\"@id\":\"https:\/\/cardiateam.eu\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/cardiateam.eu\/#\/schema\/person\/8d3259e0b35aa41c93af6f7c3d340ca4\",\"name\":\"admin2269\",\"url\":\"https:\/\/cardiateam.eu\/index.php\/author\/admin2269\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i - Cardiateam","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/","og_locale":"en_GB","og_type":"article","og_title":"Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i - Cardiateam","og_description":"Authors: Makoto\u00a0Harada, Jonathan\u00a0Adam, Marcela\u00a0Covic, Jianhong\u00a0Ge, Stefan\u00a0Brandmaier, Caroline\u00a0Muschet, Jialing\u00a0Huang, Siyu\u00a0Han, Martina\u00a0Rommel, Markus\u00a0Rotter, Margit\u00a0Heier, Robert P.\u00a0Mohney, Jan\u00a0Krumsiek, Gabi\u00a0Kastenm\u00fcller, Wolfgang\u00a0Rathmann, Zhongmei\u00a0Zou, Sven\u00a0Zukunft, Markus F.\u00a0Scheerer, Susanne\u00a0Neschen, Jerzy\u00a0Adamski, Christian\u00a0Gieger, Annette\u00a0Peters, Donna P.\u00a0Ankerst, Thomas\u00a0Meitinger, Tanya L.\u00a0Alderete, Martin Hrabe\u00a0de\u00a0Angelis Karsten\u00a0Suhre and Rui\u00a0Wang-Sattler &nbsp; Harada et al. Cardiovascular Diabetology (2024) 23:199 doi: https:\/\/doi.org\/10.1186\/s12933-024-02288-x Published: 12 June 2024 &nbsp; Abstract: Background Metformin and sodium-glucose-cotransporter-2&hellip;","og_url":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/","og_site_name":"Cardiateam","article_published_time":"2026-01-16T10:20:57+00:00","og_image":[{"width":316,"height":446,"url":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/8.webp","type":"image\/webp"}],"author":"admin2269","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin2269","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#article","isPartOf":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/"},"author":{"name":"admin2269","@id":"https:\/\/cardiateam.eu\/#\/schema\/person\/8d3259e0b35aa41c93af6f7c3d340ca4"},"headline":"Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i","datePublished":"2026-01-16T10:20:57+00:00","mainEntityOfPage":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/"},"wordCount":421,"publisher":{"@id":"https:\/\/cardiateam.eu\/#organization"},"image":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#primaryimage"},"thumbnailUrl":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/8.webp","articleSection":["Publications"],"inLanguage":"en-GB"},{"@type":"WebPage","@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/","url":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/","name":"Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i - Cardiateam","isPartOf":{"@id":"https:\/\/cardiateam.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#primaryimage"},"image":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#primaryimage"},"thumbnailUrl":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/8.webp","datePublished":"2026-01-16T10:20:57+00:00","breadcrumb":{"@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#primaryimage","url":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/8.webp","contentUrl":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2026\/01\/8.webp","width":316,"height":446},{"@type":"BreadcrumbList","@id":"https:\/\/cardiateam.eu\/index.php\/2026\/01\/16\/bidirectional-modulation-of-tca-cycle-metabolites-and-anaplerosis-by-metformin-and-its-combination-with-sglt2i\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/cardiateam.eu\/"},{"@type":"ListItem","position":2,"name":"Bidirectional modulation of TCA cycle metabolites and anaplerosis by metformin and its combination with SGLT2i"}]},{"@type":"WebSite","@id":"https:\/\/cardiateam.eu\/#website","url":"https:\/\/cardiateam.eu\/","name":"Cardiateam","description":"Assessment of the uniqueness of diabetic cardiomyopathy relative to other forms of heart failure using unbiased pheno-mapping approaches","publisher":{"@id":"https:\/\/cardiateam.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cardiateam.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/cardiateam.eu\/#organization","name":"Cardiateam","url":"https:\/\/cardiateam.eu\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/cardiateam.eu\/#\/schema\/logo\/image\/","url":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2019\/07\/cropped-CARDIATEAM-logo-1.png","contentUrl":"https:\/\/cardiateam.eu\/wp-content\/uploads\/2019\/07\/cropped-CARDIATEAM-logo-1.png","width":3486,"height":1434,"caption":"Cardiateam"},"image":{"@id":"https:\/\/cardiateam.eu\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cardiateam.eu\/#\/schema\/person\/8d3259e0b35aa41c93af6f7c3d340ca4","name":"admin2269","url":"https:\/\/cardiateam.eu\/index.php\/author\/admin2269\/"}]}},"_links":{"self":[{"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/posts\/973","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/comments?post=973"}],"version-history":[{"count":1,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/posts\/973\/revisions"}],"predecessor-version":[{"id":975,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/posts\/973\/revisions\/975"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/media\/974"}],"wp:attachment":[{"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/media?parent=973"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/categories?post=973"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cardiateam.eu\/index.php\/wp-json\/wp\/v2\/tags?post=973"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}